Indigestion Relief (Ranitidine Hydrochloride)

Ranitidine, the active ingredient in Indigestion Relief, is a H2 receptor antagonist presented as an oral tablet for oral use. It helps relieve symptoms of dyspepsia, heartburn, gastro‑oesophageal reflux disease and peptic ulcer disease in adult patients. GNH USA supplies Indigestion Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ranitidine acts on the histamine H2‑receptor pathway to reduce gastric acidity, making it useful for several upper‑gastrointestinal conditions. - Dyspepsia: provides symptomatic relief of upper abdominal discomfort and fullness. - Heartburn: reduces the frequency and intensity of burning sensations in the chest. - Gastro‑oesophageal reflux disease (GERD): decreases reflux episodes and associated irritation. - Peptic ulcer disease: supports healing by lowering gastric acid exposure to ulcer sites.

Ranitidine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Dizziness: sensation of light‑headedness or unsteadiness. - Constipation: reduced bowel movements or hard stools. - Nausea: feeling of queasiness or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of swelling, rash, and breathing difficulty. - Hepatic dysfunction: abnormal liver enzyme elevations or hepatitis. - Neutropenia: marked reduction in neutrophil count increasing infection risk.

Before initiating therapy, certain safety considerations should be observed. - Assess renal function: adjust use in patients with impaired kidney clearance. - Monitor liver enzymes: watch for signs of hepatic injury during treatment. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use with caution in the elderly: increased susceptibility to adverse effects. - Store at room temperature: keep in the original pack, protect from moisture.

Ranitidine can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption. - Cimetidine: additive H2‑blockade may cause excessive acid suppression. - Atazanavir: decreased antiviral efficacy. - Antacids containing aluminum or magnesium: may interfere with ranitidine absorption.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect. - Theophylline: possible increase in plasma concentrations. - Digoxin: may enhance digoxin levels.